AUA 2024: Impact of 18F-DCFPyL on Accuracy of mpMRI in Men with Low and Intermediate Risk Prostate Cancer: Interim Analysis of a Phase II Diagnostic Trial
AUA 2024, Prostate Cancer, 18F-DCFPyL, Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography (PSMA-PET), PRIMARY trial, impact of 18F-DCFPyL on the accuracy of mpMRI, combined mpMRI + PSMA-PET/CT.